Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TTK Enzyme Assay from US Patent US11884671: "Purinone compounds and their use in treating cancer"
Assay data:46 Active, 22 Activity ≤ 1 µM, 51 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
HPK1 Kinase Assay (Biochemical Assay) from US Patent US20240025922: "TETRAHYDROPYRIDO[3,4-d]PYRIMIDINES AS HPK1 INHIBITORS"
Assay data:181 Active, 187 Activity ≤ 1 µM, 187 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
In Vitro DGKα and DGKζ Inhibition Assay from US Patent US20240025900: "TETRACYCLIC COMPOUNDS AS DGK INHIBITORS"
Assay data:9 Active, 9 Activity ≤ 1 µM, 9 Tested
Biochemical Assay from US Patent US20240025884: "COMPOUNDS AS GCN2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF"
Assay data:498 Active, 503 Activity ≤ 1 µM, 503 Tested
HTRF Assay from US Patent US20240018153: "BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF"
Assay data:13 Active, 13 Activity ≤ 1 µM, 13 Tested
Assay data:10 Active, 10 Activity ≤ 1 µM, 10 Tested
Assay data:11 Active, 11 Activity ≤ 1 µM, 11 Tested
ADP-GLO Kinase Assay from US Patent US20240018151: "NOVEL INHIBITORS OF PIKFYVE AND METHODS USING SAME"
Assay data:8 Active, 10 Activity ≤ 1 µM, 10 Tested
UDP-Glo Glucosylceramide Synthase Biochemical Assay from US Patent US20240018140: "MODIFIED IMIDAZOPYRIDINES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS"
Assay data:83 Active, 14 Activity ≤ 1 nM, 83 Activity ≤ 1 µM, 83 Tested
Biochemical Assay from US Patent US20240016810: "COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF NEUROLOGICAL DISORDERS"
Assay data:21 Active, 1 Activity ≤ 1 nM, 15 Activity ≤ 1 µM, 26 Tested
A2A Tag-lite HTRF Assay from US Patent US11873304: "Fused pyrimidine derivatives as A2A/A2B inhibitors"
Assay data:34 Active, 34 Activity ≤ 1 µM, 34 Tested
Biochemical Activity ACSS2 Assay from US Patent US20240009175: "TETRAZOLE DERIVATIVES"
Assay data:51 Active, 7 Activity ≤ 1 nM, 50 Activity ≤ 1 µM, 51 Tested
HEK Reporter Assay from US Patent US20240042050: "ANTI-HER2 IMMUNOCONJUGATES, AND USES THEREOF"
Assay data:16 Active, 12 Activity ≤ 1 µM, 16 Tested
FLIPR Assay from US Patent US11891403: "Tetrazole derivatives as TRPA1 inhibitors"
Assay data:24 Active, 24 Activity ≤ 1 µM, 24 Tested
[35S]-GTPgammaS binding assay from US Patent US20240050427: "TREATMENTS FOR OBSESSIVE COMPULSIVE DISORDER"
Assay data:6 Active, 6 Activity ≤ 1 µM, 6 Tested
ASK1 Enzyme Assay from US Patent US11897898: "Pyridine macrocycle compounds as ASK1 inhibiting agents"
Assay data:34 Active, 30 Activity ≤ 1 µM, 35 Tested
FGFR Enzymatic Assay from US Patent US11897891: "Tricyclic heterocycles as FGFR inhibitors"
Assay data:81 Active, 83 Activity ≤ 1 µM, 83 Tested
PDE5 assay from US Patent US11897890: "2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof"
Assay data:12 Active, 5 Activity ≤ 1 nM, 12 Activity ≤ 1 µM, 12 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on